Scarica l'app Stockscreener
99.32
1.17%
1.15
Dopo l'orario di chiusura:
99.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Precedente Chiudi:
$98.17
Aprire:
$99.85
Volume 24 ore:
606.93K
Relative Volume:
1.28
Capitalizzazione di mercato:
$6.62B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-25.47
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
+6.35%
1M Prestazione:
+14.85%
6M Prestazione:
+29.41%
1 anno Prestazione:
+12.24%
Intervallo 1D:
$96.11
$100.77
Intervallo di 1 settimana:
$94.87
$104.90
Portata 52W:
$55.53
$104.90
Nuvalent Inc Stock (NUVL) Company Profile
Nome
Nuvalent Inc
Settore
Industria
Telefono
508-446-2272
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Confronta NUVL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
99.32 | 7.08B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Ripresa | Stifel | Buy |
| 2025-10-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-09-03 | Iniziato | Raymond James | Outperform |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-03-14 | Aggiornamento | UBS | Neutral → Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-24 | Iniziato | UBS | Neutral |
| 2024-08-29 | Iniziato | Barclays | Overweight |
| 2024-04-17 | Iniziato | Jefferies | Buy |
| 2024-04-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | Ripresa | Guggenheim | Buy |
| 2024-02-23 | Iniziato | Robert W. Baird | Outperform |
| 2023-09-27 | Iniziato | Stifel | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Market Perform |
| 2023-07-24 | Iniziato | Guggenheim | Buy |
| 2023-01-18 | Iniziato | Wedbush | Outperform |
| 2022-06-24 | Iniziato | BMO Capital Markets | Outperform |
Mostra tutto
Nuvalent Inc Borsa (NUVL) Ultime notizie
Published on: 2025-11-02 12:56:55 - newser.com
Can volume confirm reversal in Nuvalent Inc.2025 Technical Overview & Community Consensus Picks - newser.com
How risky is Nuvalent Inc. stock nowJuly 2025 Intraday Action & Fast Gain Stock Tips - newser.com
Will Nuvalent Inc. stock rally after Fed decisionsRate Hike & AI Enhanced Trading Alerts - newser.com
Published on: 2025-11-02 03:40:29 - newser.com
Why analysts remain bullish on Nuvalent Inc. stockJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
Statistical indicators supporting Nuvalent Inc.’s strengthWeekly Gains Summary & Daily Chart Pattern Signals - newser.com
Can Nuvalent Inc. stock outperform in 2025 bull marketMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Nuvalent (NASDAQ:NUVL) Insider Deborah Ann Miller Sells 21,800 Shares - MarketBeat
Applying sector rotation models to Nuvalent Inc.Weekly Trading Summary & Pattern Based Trade Signal System - newser.com
What data driven models say about Nuvalent Inc.’s future2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com
Will Nuvalent Inc. bounce back from current supportPortfolio Performance Report & Free Accurate Trade Setup Notifications - newser.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Centene (CNC) and Nuvalent (NUVL) - The Globe and Mail
Nuvalent Inc Reports Q3 2025 EPS of -$1.70, Missing Estimates; S - GuruFocus
What moving averages say about Nuvalent Inc.July 2025 Update & Breakout Confirmation Trade Signals - newser.com
Nuvalent price target raised to $120 from $105 at Goldman Sachs - TipRanks
Nuvalent (NASDAQ:NUVL) Announces Earnings Results - MarketBeat
Barclays Raises Price Target for Nuvalent (NUVL) to $112.00 | NU - GuruFocus
Nuvalent stock price target raised to $132 by UBS on cancer drug progress - Investing.com Canada
Nuvalent price target raised to $132 from $114 at UBS - TipRanks
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Nuvalent (NUVL) - The Globe and Mail
Using economic indicators to assess Nuvalent Inc. potential2025 Stock Rankings & Long-Term Safe Investment Plans - newser.com
Why Nuvalent Inc. stock is trending among retail traders2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
Nuvalent, Inc. Reports Q3 2025 Progress and Financials - TipRanks
Decoding Nuvalent Inc (NUVL): A Strategic SWOT Insight - GuruFocus
Insider Selling: Nuvalent (NASDAQ:NUVL) Director Sells $1,437,799.35 in Stock - MarketBeat
Insider Selling: Nuvalent (NASDAQ:NUVL) Director Sells 32,455 Shares of Stock - MarketBeat
FY2026 EPS Estimates for Nuvalent Decreased by Analyst - MarketBeat
Nuvalent’s Cash Cushion Keeps Investors On Board Through Setbacks - Finimize
Nuvalent Q3 Net Loss Widens - MarketScreener
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results - The Malaysian Reserve
Custom strategy builders for tracking Nuvalent Inc.Portfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Nuvalent (NASDAQ: NUVL) completes zidesamtinib NDA; cash runway anticipated into 2028 - Stock Titan
Nuvalent’s Zidesamtinib Study: A Potential Game-Changer in Cancer Treatment - The Globe and Mail
Nuvalent (NASDAQ:NUVL) Reaches New 12-Month HighShould You Buy? - MarketBeat
Piper Sandler raises Nuvalent stock price target to $128 on ALK opportunity By Investing.com - Investing.com Nigeria
Nuvalent Inc Azioni (NUVL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):